Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio

Kite Pharma Inc (KITE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2016	12-2015	12-2014	12-2013	12-2012
Cash Flows From Operating Activities
Net Income	-267,070	-101,653	-42,569	-6,366	-2,573
Depreciation Amortization	12,215	5,236	262	17	9
Income taxes - deferred	-2,895	N/A	N/A	N/A	N/A
Accounts payable and accrued liabilities	2,255	4,534	1,937	255	52
Other Working Capital	15,667	38,761	2,957	622	-274
Other Operating Activity	70,924	34,090	20,341	-140	0
Operating Cash Flow	$-168,904	$-19,032	$-17,072	$-5,612	$-2,786

Cash Flows From Investing Activities
Change In Deposits	-86,770	-65,277	-158,039	N/A	N/A
PPE Investments	-20,146	-26,573	-2,100	-279	-2
Net Acquisitions	N/A	-14,690	N/A	N/A	N/A
Purchase Of Investment	-6,025	N/A	N/A	N/A	N/A
Investing Cash Flow	$-112,941	$-106,540	$-160,139	$-279	$-2

Cash Flows From Financing Activities
Debt Issued	N/A	N/A	50,000	N/A	250
Debt Repayment	-126	-16	-17	N/A	N/A
Common Stock Issued	3,711	307,679	337,754	N/A	5
Common Stock Repurchased	2,369	1,405	N/A	N/A	N/A
Other Financing Activity	-2,259	0	-23,585	19,597	0
Financing Cash Flow	$3,695	$309,068	$364,152	$19,597	$255

Exchange Rate Effect	-132	49	N/A	N/A	N/A
Beginning Cash Position	392,843	209,298	22,357	8,651	11,184
End Cash Position	114,561	392,843	209,298	22,357	8,651
Net Cash Flow	$-278,282	$183,545	$186,941	$13,706	$-2,533

Free Cash Flow
Operating Cash Flow	-168,904	-19,032	-17,072	-5,612	-2,786
Capital Expenditure	-20,146	-26,573	-2,100	-279	-2
Free Cash Flow	-189,050	-45,605	-19,172	-5,891	-2,788